세계 통증 한랭요법 시장 - 제품별, 용도별, 유통 채널별 : 기회 분석과 산업 예측(2023-2032년)

Cold Pain Therapy Market By Product, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 8,290,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,890,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

통증 한랭요법 시장은 2022년에는 19억 달러로 평가되었으며, 2023년부터 2032년까지의 CAGR은 5.1%를 기록했으며, 2032년에는 30억 4,000만 달러에 이를 것으로 추정됩니다.

크라이오 테라피는 한랭 치료를 의미합니다. 한랭 요법에는 아이스팩, 냉각 스프레이, 아이스 마사지, 아이스 목욕 등 다양한 방법이 있습니다. 가정에서 부상을 치료하는 데 사용되는 경우, 크라이오 테라피는 일반적으로 냉동고에 필요한 때까지 넣어 두는 얼음이나 젤 팩에 의한 한랭 요법을 말합니다. 이들은 통증과 붓기를 관리하는 가장 간단하고 오랜 역사를 가진 치료법 중 하나입니다.

한랭 요법은 염증을 억제하는 데 도움이 됩니다. 급성 부상이나 통증에 사용하는 것이 가장 효과적입니다. 관절과 힘줄 주위의 조직 손상을 줄이는 속도를 늦추는 데 도움이 됩니다. 한랭 요법은 아픈 근육 조직을 마비시키고 거의 마취제처럼 작용합니다. 또한 뇌에 전해지는 통증의 신호를 지연시키는 효과도 있습니다. 차가운 찜질은 일반적인 부상의 일반적인 가정에서의 치료법인 RICE(안정, 얼음, 압박, 거상)의 일부입니다.

세계 통증 한랭요법 시장의 성장을 가속하는 주요 요인으로는 근골격계 질환, 관절염, 변형성 관절증, 관절장애 등 증가, 보다 세련되고 사용하기 쉬운 통증 한랭요법 제품의 개발로 이어졌습니다 기술 진보의 급증 등이 있습니다. 또한 고령화 인구 증가와 통증 치료제의 장기간 사용과 관련된 잠재적 부작용과 위험에 대한 의식이 높아짐에 따라 비 약리적 통증 관리에 대한 수요를 높이고 시장 성장을 가속하는 주요 요인 되어 있습니다. 또한 주요 시장 기업 증가와 기술적으로 고급 콜드 페인 테라피 제품의 개발을 위해 채택하는 전략은 콜드 페인 테라피 시장의 성장을 뒷받침하는 주요 요인입니다.

예를 들어, 2023년 3월, 가동성 및 통증 관리 솔루션으로 업계를 선도하는 Aspen Medical Products (Aspen)와 스포츠 및 상해 회복 분야의 선도적인 공급업체인 NICE Recovery Systems(NICE)는 환자와 의료 전문가에게 보다 정확한 회복과 통증 관리 솔루션을 제공하기 위한 전략적 제휴를 발표했습니다. 이 파트너십은 NICE의 고급 저온 압박 기술과 아스펜의 효과적인 장비 솔루션을 활용하여 수술과 부상으로부터 회복된 환자에게 통증 관리 및 수술 후 관리를 제공합니다.

그러나 통증을 즉시 완화하기 위해 저가의 진통제가 사용되고 있거나 유리한 상환이 없는 것이 냉통 요법 시장의 성장을 억제하고 있습니다. 반대로 진통 패치의 채용이 증가함에 따라 예측 기간 동안 콜드 페인 테라피 시장이 성장할 수있는 유리한 기회가 생길 것으로 기대됩니다.

냉통 요법 시장은 제품, 용도, 유통 채널, 지역으로 구분됩니다. 제품 기반에서 시장은 OTC 제품과 처방 제품으로 이분됩니다. OTC 제품은 또한 크림, 젤, 패치, 그리고 처방전 제품은 전기 및 비 전기 장비로 세분화됩니다. 용도별로는 근골격계 장애, 수술 후 요법, 스포츠 부상, 외상 후 요법으로 분류됩니다. 유통 채널별로는 병원 약국, 소매 약국, 온라인 약국으로 구분됩니다.

지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽), 아시아태평양(중국, 일본, 호주, 인도, 한국, 기타 아시아태평양), 라틴 미국(브라질, 콜롬비아, 아르헨티나 및 기타 아시아태평양), 중동 아메리카(GCC, 콜롬비아, 아르헨티나 및 기타 남미)에서 분석됩니다.

이해관계자를 위한 주요 이점

• 본 보고서에서는 2022년부터 2032년까지의 통증 한랭요법 시장 분석 시장 부문, 현재의 동향, 추정·동향, 역학을 정량적으로 분석하여 일반적인 통증 한랭요법 시장 기회를 확인합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자들이 이익에 중점을 둔 비즈니스 결정을 내리고 공급업체와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 힘을 강조합니다.
• 콜드 페인 테라피 시장 세분화를 자세히 분석하여 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 냉통 요법 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략의 분석이 포함되어 있습니다.

기타 구매 혜택은 다음과 같습니다.

• 분기별 최신 정보 및 *(사업자 라이선스 만 표시 가격으로 제공됩니다)
• 구입 전 또는 구입 후 원하는 기업 프로파일을 5개사 추가로 무료 업데이트.
• 5 사용자 라이선스 및 엔터프라이즈 사용자 라이선스 구매의 경우 다음 버전을 무료로 제공합니다.
• 애널리스트가 16시간 지원*(구매 후 보고서 검토에서 추가 데이터 요구사항이 발견되면 애널리스트가 16시간 지원을 받아 질문 및 판매 후 문의를 해결할 수 있습니다.)
• 15% 무료 맞춤설정*(보고서의 조사 범위 또는 부문이 고객의 요구사항과 일치하지 않는 경우 15%는 3영업일 무료 작업에 해당합니다.)
• 5 사용자 라이선스 및 엔터프라이즈 사용자 라이선스의 무료 데이터 팩.(엑셀판 보고서)
• 보고서가 6-12개월 이상 전인 경우, 갱신 보고서를 무료로 제공.
• 24시간 우선 대응*.
• 업계의 최신 정보와 백서를 무료로 제공
  
• 본 보고서의 커스터마이즈가 가능(별도 비용과 스케줄이 걸립니다.)
• 규제 가이드라인
• 고객의 관심에 따른 추가 기업 프로파일
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 예측
• 기업 프로파일의 확장 목록
• 과거 시장 데이터
• 주요 기업의 상세(소재지, 연락처, 공급자/벤더 네트워크 등을 포함한 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 스포츠 관련 부상 증가
    • 수술 수술 증가
    • 외상성 손상 사례 증가
  • 억제요인
    • 통증 완화를위한 저렴한 가격 진통제의 가용성
  • 기회
    • 근골격계 질환의 유병률 증가

제4장 통증 한랭요법 시장 : 제품별

• 개요
• OTC 제품
  • OTC 제품 유형별 냉통 치료 시장
• 처방 제품
  • 처방 제품 유형별 냉통 요법 시장

제5장 통증 한랭요법 시장 : 용도별

• 개요
• 근골격계 장애
• 수술후 요법
• 스포츠 상해
• 외상 후 요법

제6장 통증 한랭요법 시장 : 유통 채널별

• 개요
• 병원 약국
• 소매 약국
• 온라인 약국

제7장 통증 한랭요법시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 브라질
  • 콜롬비아
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • Gcc
  • 남아프리카
  • 북아프리카
  • 기타

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제9장 기업 프로파일

• Cardinal Health Inc.
• Sanofi
• Medline Industries, LP
• Beiersdorf AG
• ThermoTek Inc
• 3M Company
• Hisamitsu Pharmaceutical Co.,Inc.
• Bruder Healthcare Company LLC
• Ossur
• Romsons Group of Industries Pvt. Ltd.

JHS

영문 목차

영문목차

The cold pain therapy market was valued at $1.9 billion in 2022 and is estimated to reach $3.04 billion by 2032, exhibiting a CAGR of 5.1%from 2023 to 2032.

Cryotherapy means cold therapy. Cryotherapy can be applied in various ways, including icepacks, coolant sprays, ice massage, and whirlpools, or ice baths. When used to treat injuries at home, cryotherapy refers to cold therapy with ice or gel packs that are usually kept in the freezer until needed. These remain one of the simplest, time-tested remedies for managing pain and swelling.

Cold therapy helps reduce inflammation. It's most helpful when used for acute injuries and pain. It aids in slowing the rate of reducing tissue damage around a joint or tendon. Cold therapy can numb sore muscle tissue, almost acting as an anesthetic. It has the ability to slow down the pain signals that are transmitted to the brain. Cold compresses are part of a common at-home treatment for standard injuries - RICE - Rest, ice, compression, elevation.

Major factors that drive the growth of the global cold pain therapy market include a rise in the number of musculoskeletal disorders, arthritis, osteoarthritis, joint disorders and others, upsurge in technological advancement that have led to the development of more sophisticated and user-friendly cold pain therapy products. Furthermore, the growing aging population and growing awareness of the potential side effects and risks associated with long-term use of pain medications are the major factors that increase the demand for non-pharmacological pain management and hence propel the growth of the market. In addition, the increase in the number of key market players and the strategies they adopt for the development of technologically advanced cold pain therapy products are the major factors that boost the growth of the cold pain therapy market.

For instance, in March 2023, Aspen Medical Products (Aspen), the industry leader in solutions for mobility and pain management, and NICE Recovery Systems (NICE), a leading provider in the sports and injury recovery space, announced a strategic partnership that aims to bring more precise recovery and pain management solutions to patients and medical professionals. The partnership leverages NICE's advanced cold compression technology with Aspen's effective bracing solutions to deliver pain management and post-operative care to patients recovering from surgery or injury.

However, the growing use of low-priced analgesic pills for immediate pain relief and lack of favorable reimbursement restrain the growth of the cold pain therapy market. On the contrary, the increase in the adoption of analgesic patches is expected to provide lucrative opportunities for the cold pain therapy market to grow during the forecast period.

The cold pain therapy market is segmented into product, application, distribution channel, and region. On the basis of product, the market is bifurcated into OTC products and prescription products. The OTC products are further bifurcated into creams, gels, patches and others and the prescription products are sub-segmented into motorized devices and non-motorized devices. On the basis of application, it is segregated into musculoskeletal disorders, post-operative therapies, sport injuries and post-trauma therapy. On the basis of distribution channel, it is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and Latin America (Brazil, Colombia, Argentina, Rest of LA) and Middle East and Africa (GCC, South Africa, North Africa, Rest of MEA)

The major players profiled in the report are Romsons Group of Industries, Cardinal Health Inc, Sanofi, Breg Inc., Medline Industries LP, Ossur, Hisamitsu Pharmaceutical Inc, Beiersdorf AG, 3M and ThermoTek Inc. The key players such as ThermoTek Inc and Hisamitsu Pharmaceutical Inc have adopted expansion as major developmental strategies to improve the product portfolio

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cold pain therapy market analysis from 2022 to 2032 to identify the prevailing cold pain therapy market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cold pain therapy market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cold pain therapy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.
  
• Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

• OTC Products
  • Type
  • Creams
  • Gels
  • Patches
  • Others
• Prescription Products
  • Type
  • Motorized Devices
  • Non Motorized Devices

By Application

• Musculoskeletal Disorders
• Post-Operative Therapy
• Sports Injuries
• Post-Trauma Therapy

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Colombia
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Gcc
  • South Africa
  • North Africa
  • Rest Of Mea

Key Market Players:

• Sanofi
• Beiersdorf AG
• 3M Company
• Medline Industries, LP
• Ossur
• Romsons Group of Industries Pvt. Ltd.
• Cardinal Health Inc.
• ThermoTek Inc
• Hisamitsu Pharmaceutical Co.,Inc.
• Bruder Healthcare Company LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in the number of sports related injuries.
    • 3.4.1.2. Increase in the number of surgical procedures.
    • 3.4.1.3. Rise in the number of traumatic injury cases.
  • 3.4.2. Restraints
    • 3.4.2.1. Availability of low-priced analgesic pills for pain relief
  • 3.4.3. Opportunities
    • 3.4.3.1. Rise in the prevalence of musculoskeletal disorders.

CHAPTER 4: COLD PAIN THERAPY MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. OTC Products
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. OTC Products Cold Pain Therapy Market by Type
• 4.3. Prescription Products
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
  • 4.3.4. Prescription Products Cold Pain Therapy Market by Type

CHAPTER 5: COLD PAIN THERAPY MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Musculoskeletal Disorders
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Post-Operative Therapy
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Sports Injuries
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Post-Trauma Therapy
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals Pharmacies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Retail Pharmacies
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Online Pharmacies
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: COLD PAIN THERAPY MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by Distribution Channel
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product
    • 7.2.5.1.2. Market size and forecast, by Application
    • 7.2.5.1.3. Market size and forecast, by Distribution Channel
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product
    • 7.2.5.2.2. Market size and forecast, by Application
    • 7.2.5.2.3. Market size and forecast, by Distribution Channel
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product
    • 7.2.5.3.2. Market size and forecast, by Application
    • 7.2.5.3.3. Market size and forecast, by Distribution Channel
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by Distribution Channel
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product
    • 7.3.5.1.2. Market size and forecast, by Application
    • 7.3.5.1.3. Market size and forecast, by Distribution Channel
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Product
    • 7.3.5.2.2. Market size and forecast, by Application
    • 7.3.5.2.3. Market size and forecast, by Distribution Channel
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Product
    • 7.3.5.3.2. Market size and forecast, by Application
    • 7.3.5.3.3. Market size and forecast, by Distribution Channel
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Product
    • 7.3.5.4.2. Market size and forecast, by Application
    • 7.3.5.4.3. Market size and forecast, by Distribution Channel
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Product
    • 7.3.5.5.2. Market size and forecast, by Application
    • 7.3.5.5.3. Market size and forecast, by Distribution Channel
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product
    • 7.3.5.6.2. Market size and forecast, by Application
    • 7.3.5.6.3. Market size and forecast, by Distribution Channel
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by Distribution Channel
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Product
    • 7.4.5.1.2. Market size and forecast, by Application
    • 7.4.5.1.3. Market size and forecast, by Distribution Channel
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Product
    • 7.4.5.2.2. Market size and forecast, by Application
    • 7.4.5.2.3. Market size and forecast, by Distribution Channel
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Product
    • 7.4.5.3.2. Market size and forecast, by Application
    • 7.4.5.3.3. Market size and forecast, by Distribution Channel
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Product
    • 7.4.5.4.2. Market size and forecast, by Application
    • 7.4.5.4.3. Market size and forecast, by Distribution Channel
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Product
    • 7.4.5.5.2. Market size and forecast, by Application
    • 7.4.5.5.3. Market size and forecast, by Distribution Channel
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product
    • 7.4.5.6.2. Market size and forecast, by Application
    • 7.4.5.6.3. Market size and forecast, by Distribution Channel
• 7.5. Latin America
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by Distribution Channel
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product
    • 7.5.5.1.2. Market size and forecast, by Application
    • 7.5.5.1.3. Market size and forecast, by Distribution Channel
    • 7.5.5.2. Colombia
    • 7.5.5.2.1. Market size and forecast, by Product
    • 7.5.5.2.2. Market size and forecast, by Application
    • 7.5.5.2.3. Market size and forecast, by Distribution Channel
    • 7.5.5.3. Argentina
    • 7.5.5.3.1. Market size and forecast, by Product
    • 7.5.5.3.2. Market size and forecast, by Application
    • 7.5.5.3.3. Market size and forecast, by Distribution Channel
    • 7.5.5.4. Rest of Latin America
    • 7.5.5.4.1. Market size and forecast, by Product
    • 7.5.5.4.2. Market size and forecast, by Application
    • 7.5.5.4.3. Market size and forecast, by Distribution Channel
• 7.6. Middle East and Africa
  • 7.6.1. Key market trends, growth factors and opportunities
  • 7.6.2. Market size and forecast, by Product
  • 7.6.3. Market size and forecast, by Application
  • 7.6.4. Market size and forecast, by Distribution Channel
  • 7.6.5. Market size and forecast, by country
    • 7.6.5.1. Gcc
    • 7.6.5.1.1. Market size and forecast, by Product
    • 7.6.5.1.2. Market size and forecast, by Application
    • 7.6.5.1.3. Market size and forecast, by Distribution Channel
    • 7.6.5.2. South Africa
    • 7.6.5.2.1. Market size and forecast, by Product
    • 7.6.5.2.2. Market size and forecast, by Application
    • 7.6.5.2.3. Market size and forecast, by Distribution Channel
    • 7.6.5.3. North Africa
    • 7.6.5.3.1. Market size and forecast, by Product
    • 7.6.5.3.2. Market size and forecast, by Application
    • 7.6.5.3.3. Market size and forecast, by Distribution Channel
    • 7.6.5.4. Rest Of Mea
    • 7.6.5.4.1. Market size and forecast, by Product
    • 7.6.5.4.2. Market size and forecast, by Application
    • 7.6.5.4.3. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Cardinal Health Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Sanofi
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Medline Industries, LP
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
• 9.4. Beiersdorf AG
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. ThermoTek Inc
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
• 9.6. 3M Company
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
• 9.7. Hisamitsu Pharmaceutical Co.,Inc.
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. Bruder Healthcare Company LLC
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
• 9.9. Ossur
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Romsons Group of Industries Pvt. Ltd.
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio

관련자료